Here, by modeling adjuvant (i.e., postsurgical) therapy targeting ALK1 in experimental metastatic breast cancer, we characterize a previously overlooked subpopulation of tumor-associated macrophages (TAMs) identified by expression of Acvrl1. The gene discussed is ALK; the disease is neoplasm.